In the evolving landscape of cancer care In the evolving landscape of cancer care, the use of circulating tumor DNA (ctDNA), also known as liquid biopsies, is becoming increasingly significant in the management of colorectal cancer. This is true regardless of the stage at diagnosis. Recent discussions and studies have shed light on how ctDNA … Continue reading Pashtoon Kasi MD, MS – The Role of Circulating Tumor DNA (ctDNA) in Colorectal Cancer Management – ASCO GI 2025